Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk

Cancer Detection and Prevention

Volumn 30, Issue 6, 2006, Pages 523-529

  Damin, Andrea P S ^a   Frazzon, Ana P G ^a   Damin, Daniel C ^a   Roehe, Adriana ^a   Hermes, Vanessa ^a   Zettler, Claudio ^a,b   Alexandre, Claudio O P ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Complexo Hospitalar Santa Casa ^*  (Brazil)

Author keywords

Arginine proline; Brazil; Breast cancer; Codon 72; Hardy Weinberg equilibrium; Polymerase chain reaction restriction fragment length polymorphism, PCR RFLP; Polymorphism; Risk factors; Sequencing; TP53; TP53 genotypes

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BRAZIL; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARGININE; BRAZIL; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; CODON; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROLINE; RISK FACTORS;

EID: 34548242532     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.09.007     Document Type: Article

References (52)

1. Kamangar F., Dores M.G., and Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24 (2006) 2137-2150
2. Ministerio da Saude: Cancer incidence and mortality in Brazil. Brasilia: Instituto Nacional do Cancer (INCA), Ministério da Saúde; 2005.
3. Veronesi U., Boyle P., Golsdhirsch A., Orecchia R., and Viale G. Breast cancer. Lancet 365 (2005) 1727-1741
4. Yager J.D., and Davidson N.E. Mechanism of disease: estrogen carcinogenesis in breast cancer. N Engl J Med 354 (2006) 270-282
5. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
6. Dumitrescu R.G., and Cotarla I. Understanding breast cancer risk-where do we stand in 2005?. J Cell Mol Med 9 (2005) 208-221
7. Hainaut P., and Hollstein M. p53 and human cancer: the first thousand mutations. Adv Cancer Res 77 (2000) 81-137
8. Borresen-Dale A. p53 review article: TP53 and breast cancer. Hum Mutat 21 (2003) 292-300
9. Fan R., Wu M.T., Miller D., Wain J.C., Kelsey K.T., Wiencke J.K., et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9 (2000) 1037-1042
10. Soulitzis N., Sourvinos G., Dokianakis D.N., and Spandidos D.A. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179 (2002) 175-183
11. Papadakis E.N., Dokianakis D.N., and Spandidos D.A. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun 3 (2000) 389-392
12. Harris N., Brill E., Shohat O., Prokocimer M., Wolf D., Arai N., et al. Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6 (1986) 4650-4656
13. Dumont P., Leu J.I., Della Pietra III A.C., George D.L., and Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33 (2003) 357-365
14. Pim D., and Banks L. p53 polymorphism variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108 (2004) 196-199
15. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
16. Suspitsin E.N., Buslov K.G., Grigoriev M.Y., Isbutkina J.G., Ulibina J.M., Gorodinskaya V.M., et al. Evidence against involvement of p53 polymorphism in breast cancer predisposition. Int J Cancer 103 (2003) 431-433
17. Koushik A., Platt R.W., and Franco E.L. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13 (2004) 11-22
18. Zhang Z.W., Laurence N.J., Hollowood A., Newcomb P., Moorghen M., Gupta J., et al. Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma. Clin Cancer Res 10 (2004) 131-135
19. Beckman G., Birgander R., Sjalander A., Saha N., Holmberg P.A., Kivela A., et al. Is p53 polymorphism maintained by natural selection?. Hum Hered 44 (1994) 266-270
20. Censo Demografico 2000: Caracteristicas da populacao e domicilio. Brasília: Instituto Brasileiro de Geografia e Estatistica (IBGE); 2005.
21. Azzopardi J.G., Chepik O.F., and Hartman W.H. The World Health Organization histological typing of breast tumors. Am J Clin Pathol 78 (1982) 806
22. Elston C.W., and Ellis I.O. The breast (1998), Churchill Livingstone, Edinburgh, UK
23. Sobin L.H., and Wittkind C.H. International Union against cancer, TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
24. Ara S., Lee P.S., Hansen M.F., and Sya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18 (1990) 4691
25. Siddique M.M., Balram C., Fiszer-Maliszewska L., Aggarwal A., Tan A., Tan P., et al. Evidence for selective expression of the p53 codo 72 polymorphism: implications in cancer development. Cancer Epidemiol Biomarkers Prev 14 (2005) 2245-2252
26. Tommiska J., Eerola H., Heinonen M., Salonen L., Kaare M., Tallila J., et al. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 11 (2005) 5098-5103
27. Klaes R., Ridder R., Schaefer U., Benner A., and von Knebel Doeberitz M. No evidence of p53 allele-specific predisposition in human papillomavirus associated cervical cancer. J Mol Med 77 (1999) 299-302
28. Kalemi T., Lambropoulos A., Gueorguiev M., Chrisafi S., Papazisis K.T., and Kotsis A. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 222 (2005) 57-65
29. Arbel-Alon S., Menezer J., Feldman N., Glezerman M., Yeremin L., and Friedman E. Codon 72 polymorphism of p53 in Israeli Jewishcervical cancer patients and healthy women. Int J Gynecol Cancer 12 (2002) 741-744
30. Rezza G., Giuliani M., Garbuglia A.R., Serraino D., Cappiello G., Migliore G., et al. Lack of association between p53 Codon-72 polymorphism and squamous intraepithelial lesions in women with, or at risk for, human immunodeficiency virus and/or human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 10 (2001) 565-566
31. Noma C., Miyoshi Y., Taguchi Y.T., Tamaki Y., and Noguchi S. Association of p53 genetic polymorphism (Arg72Pro) with receptor positive breast cancer risk in Japanese women. Cancer Lett 210 (2004) 197-203
32. Klug S.J., Wilmotte R., Santos C., Almonte M., Herrero R., Guerrero I., et al. TP53 Polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 10 (2001) 1009-1012
33. Santos A.M., Sousa H., Catarino R., Pinto D., Pereira D., Vasconcelos A., et al. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal. Cancer Genet Cytogenet 159 (2005) 143-147
34. Sjalander A., Birgander R., Hallmans G., Cajander S., Lenner P., Athlin L., et al. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17 (1996) 1313-1316
35. Mabrouk I., Baccouche S., El-Abed R., Mokdad-Gargouri R., Mosbah A., Said S., et al. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann NY Acad Sci 1010 (2003) 764-770
36. Madeleine M.M., Shera K., Schwartz F.M., Daling J.R., Galloway D.A., Wipf G.C., et al. The p53 codon 72 polymorphism, human papillomavirus, and invasive squamous cell cancer. Cancer Epidemiol Biomarkers Prev 9 (2000) 225-227
37. Osborne R.J., Merlo G.R., Mitsudomi T., Venesio T., Liscia D.S., Cappa A.P., et al. Mutation in the p53 gene in primary human breast cancers. Cancer Res 51 (1991) 6194-6198
38. Thompson A.M., Anderson T.J., Condie A., Prosser J., Chetty U., Carter D.C., et al. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer 50 (1992) 528-532
39. Weston A., Pan C.F., Ksieski H.B., Wallenstein S., Berkowitz G.S., Tartter P.I., et al. p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 105-112
40. Buyru N., Tigli H., and Dalay N. p53 codon 72 polymorphism in breast cancer. Oncol Rep 10 (2003) 711-714
41. Gohrkei S.W., Rebbeck T.R., Besenfelder W., Kreienberg R., and Runnebaum I. Germline polymorphisms are associated with an increased risk for breast cancer in German woman. Anticancer Res 18 (1998) 2095-2100
42. Keshava C., Frye B.L., Wolff M.S., McCandies E.C., and Weston A. Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 127-130
43. Huang X.E., Hamajima N., Katsuda N., Matsuo K., Hirose K., Mizutani M., et al. Association of p53 codon Arg72Pro and p73 GC14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 10 (2003) 307-311
44. Ohayon T., Gershoni-Baruch R., Papa M.Z., Menachem T.D., Eisenberg B.S., Barzilai S., et al. The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer 92 (2005) 1144-1148
45. Sjalander A., Birgander R., Saha A., Beckman L., and Beckman G. p53 polymorphism and haplotypes show distinct differences between major ethnic groups. Hum Hered 46 (1996) 41-48
46. Sjalander A., Birgander R., Kivela A., and Beckman G. p53 polymorphism and haplotypes in different ethnic groups. Hum Hered 45 (1995) 114-119
47. Marrero A.R., Das Neves Leite F.P., De Almeida Carvalho B., Peres L.M., Kommers T.C., Da Cruz I.M., et al. Heterogeneity of the genome ancestry of individuals classified as White in the state of Rio Grande do Sul. Braz Am J Hum Biol 17 (2005) 496-506
48. Callegari-Jacques S.M., Grattapaglia D., Salzano F.M., Salamoni S.P., Crossetti S.G., and Fereira M.E. Historical genetica: spatiotemporal analysis of the formation of the Brazilian populations. Am J Hum Biol 15 (2003) 824-834
49. Damin A.P., Karam R., Zettler C.G., Caleffi M., and Alexandre C.O. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 84 (2004) 131-137
50. Zehbe I., Voglino G., Wilander E., Genta F., and Tommasinno M. Codon 72 polymorphism of the p53 and its association with cervical cancer. Lancet 354 (1999) 218-219
51. Zehbe I., Voglino G., Wilander E., Delius H., Marongui A., Edler L., et al. p53 polymorphism codon 72 genotypes and various human papillomavirus 16 E6 genotypes and risk factors for cervical cancer development. Cancer Res 61 (2001) 608-611
52. Heimann R., and Hellman S. Clinical progression of breast cancer malignant behavior: what to expect and to expect it. J Clin Oncol 18 (2000) 591-599